Screener
CorMedix CRMD Total Cost of Revenue
Discontinued — last reported Q1 '26
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Product sales, net | $121,916 | $39,082 |
| Contract revenue | 5,511 | - |
| Total Revenue | 127,427 | 39,082 |
| Cost of sales (exclusive of amortization of intangibles) | 12,005 | 1,545 |
| Amortization of intangibles | 10,300 | 52 |
| Gross profit | 105,122 | 37,485 |
| Operating Expenses: | ||
| Research and development | 7,212 | 3,193 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's total cost of revenue?
- CorMedix (CRMD) reported total cost of revenue of $12.01M in Q1 2026.
- How has CorMedix's total cost of revenue changed year-over-year?
- CorMedix's total cost of revenue increased by 677.0% year-over-year, from $1.55M to $12.01M.
- What is the long-term trend for CorMedix's total cost of revenue?
- Over 3 years (2021 to 2025), CorMedix's total cost of revenue has grown at a 429.7% compound annual growth rate (CAGR), from $148.94K to $22.14M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about CorMedix's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude